Norsyifa Harun1, Zurina Hassan2, Visweswaran Navaratnam2, Sharif M Mansor2, Mohammed Shoaib3. 1. Centre for Drug Research, Universiti Sains Malaysia, 11800, Gelugor, Penang, Malaysia. norsyifa.harun@gmail.com. 2. Centre for Drug Research, Universiti Sains Malaysia, 11800, Gelugor, Penang, Malaysia. 3. Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
Abstract
RATIONALE: Mitragynine (MG) is the primary active alkaloid extracted from the leaves of Mitragyna speciosa or kratom and exhibits pharmacological activities mediated by opioid receptors. The plant has been traditionally used for its opium and psychostimulant-like effects to increase work efficiency or as a substitute in the self-treatment of opiate addiction. OBJECTIVES: The present study was performed to investigate the discriminative stimulus effects of MG in rats. The pharmacological mechanism of MG action and its derivative, 7-hydroxymitragynine (7-HMG) with a specific focus on opioid receptor involvement was examined in rats trained to discriminate morphine from vehicle. In order to study the dual actions of MG, the effect of cocaine substitution to the MG discriminative stimulus was also performed in MG-trained rats. METHODS: Male Sprague Dawley rats were trained to discriminate MG from vehicle in a two-lever drug discrimination procedure under a tandem variable-interval (VI 60') fixed-ratio (FR 10) schedule of food reinforcement. RESULTS: Rats acquired the MG discrimination (15.0 mg/kg, i.p.) which was similar to the acquisition of morphine discrimination (5.0 mg/kg, i.p.) in another group of rats. MG substituted fully to the morphine discriminative stimulus in a dose-dependent manner, suggesting pharmacological similarities between the two drugs. The administration of 7-HMG derivative in 3.0 mg/kg (i.p.) dose engendered full generalisation to the morphine discriminative stimulus. In addition, the MG stimulus also partially generalised to cocaine (10.0 mg/kg, i.p.) stimulus. CONCLUSION: The present study demonstrates that the discriminative stimulus effect of MG possesses both opioid- and psychostimulant-like subjective effects.
RATIONALE: Mitragynine (MG) is the primary active alkaloid extracted from the leaves of Mitragyna speciosa or kratom and exhibits pharmacological activities mediated by opioid receptors. The plant has been traditionally used for its opium and psychostimulant-like effects to increase work efficiency or as a substitute in the self-treatment of opiate addiction. OBJECTIVES: The present study was performed to investigate the discriminative stimulus effects of MG in rats. The pharmacological mechanism of MG action and its derivative, 7-hydroxymitragynine (7-HMG) with a specific focus on opioid receptor involvement was examined in rats trained to discriminate morphine from vehicle. In order to study the dual actions of MG, the effect of cocaine substitution to the MG discriminative stimulus was also performed in MG-trained rats. METHODS: Male Sprague Dawley rats were trained to discriminate MG from vehicle in a two-lever drug discrimination procedure under a tandem variable-interval (VI 60') fixed-ratio (FR 10) schedule of food reinforcement. RESULTS:Rats acquired the MG discrimination (15.0 mg/kg, i.p.) which was similar to the acquisition of morphine discrimination (5.0 mg/kg, i.p.) in another group of rats. MG substituted fully to the morphine discriminative stimulus in a dose-dependent manner, suggesting pharmacological similarities between the two drugs. The administration of 7-HMG derivative in 3.0 mg/kg (i.p.) dose engendered full generalisation to the morphine discriminative stimulus. In addition, the MG stimulus also partially generalised to cocaine (10.0 mg/kg, i.p.) stimulus. CONCLUSION: The present study demonstrates that the discriminative stimulus effect of MG possesses both opioid- and psychostimulant-like subjective effects.
Entities:
Keywords:
Cocaine; Drug discrimination; Kratom; Mitragynine; Morphine; Opioid; Rats
Authors: Kenjiro Matsumoto; Leonardo T Yamamoto; Kazuo Watanabe; Shingo Yano; Jie Shan; Peter K T Pang; Dhavadee Ponglux; Hiromitsu Takayama; Syunji Horie Journal: Life Sci Date: 2005-08-16 Impact factor: 5.037
Authors: Lisa L Wilson; Soumen Chakraborty; Shainnel O Eans; Thomas J Cirino; Heather M Stacy; Chloe A Simons; Rajendra Uprety; Susruta Majumdar; Jay P McLaughlin Journal: Cell Mol Neurobiol Date: 2021-01-12 Impact factor: 4.231
Authors: Samuel Obeng; Jenny L Wilkerson; Francisco León; Morgan E Reeves; Luis F Restrepo; Lea R Gamez-Jimenez; Avi Patel; Anna E Pennington; Victoria A Taylor; Nicholas P Ho; Tobias Braun; John D Fortner; Morgan L Crowley; Morgan R Williamson; Victoria L C Pallares; Marco Mottinelli; Carolina Lopera-Londoño; Christopher R McCurdy; Lance R McMahon; Takato Hiranita Journal: J Pharmacol Exp Ther Date: 2020-12-31 Impact factor: 4.030
Authors: Elisabeth Prevete; Kim Paula Colette Kuypers; Eef Lien Theunissen; Ornella Corazza; Giuseppe Bersani; Johannes Gerardus Ramaekers Journal: Hum Psychopharmacol Date: 2021-07-26 Impact factor: 2.130